Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertapenem Prostatic Tissue Concentration
NCT02041767Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ertapenem in bacterial infection (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Prostatic concentration of ertapenem. Started Dec 2013; status: completed.
02
Drugs
ertapenem
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02041767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02041767.